TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
Canopy Growth Corp.’s (TSX:WEED) Revenue Soars in First Quarter Since Pot Legalization

Investing
Canopy Growth Corp’s (TSX:WEED) Earnings Soar in Record-Breaking Q3

Investing
Are Pot Stocks About to Plunge?

Investing
Marijuana Investors: Did You Just Miss Out on The Buying Opportunity of the Year?

Investing
Attention Investors: 2 Soaring Stocks to Watch in 2019

Investing
Is Canopy Growth Corp (TSX:WEED) Stock a Buy Before Thursday Earnings?

Tech Stocks
Next Week Is Going to Be an Earnings Bonanza: Here Are 3 Things to Look Out For

Investing
Big Reveal: A High-Growth, Explosive Opportunity That’s Trading at a Mere Fraction of Marijuana Stocks
Investing
Is Canopy Growth (TSX:WEED) Stock the Best Pot Stock to Buy Now?
Stocks for Beginners
Can New Canadian Investors Still Harvest Upside From This Crop of Weed Stocks?
